Patents by Inventor Manju Swaroop

Manju Swaroop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYCLIC COMPOUNDS FOR USE IN TREATING RETINAL DEGENERATION
    Publication number: 20230301984
    Abstract: Method embodiments are disclosed for treating retinal degeneration in a subject in need thereof. In some embodiments, the method comprises administering to the subject a therapeutically effective amount of compound, and/or a pharmaceutically acceptable salt, prodrug, solvate, hydrate, or tautomer thereof, selected from 3-(dibutylamino)-1-(1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl)propan-1-ol hydrochloride or a compound having a structure according to a formula selected from Formula I, II, or III, as described herein. In some non-limiting examples, the subject has retinitis pigmentosa, LCA, Stargardt’s macular dystrophy, cone-rod dystrophy, choroideremia or age-related macular degeneration.
    Type: Application
    Filed: July 1, 2021
    Publication date: September 28, 2023
    Applicant: The USA, as represented by the Secretary, Department of Health and Human Services
    Inventors: Anand Swaroop, Yu Holly Chen, Manju Swaroop, Wei Zheng, Gregory Tawa, Anupam Mondal, Samantha Papal, Wenwei Huang, Zhiji Luo
  • Cyclodextrin for the treatment of lysosomal storage diseases
    Patent number: 11020422
    Abstract: The invention provides for methods of treating lysosomal storage disorders and/or reduction of non-cholesterol lipids, using cyclodextrin compounds, including in combination with other therapeutics, including vitamin E.
    Type: Grant
    Filed: June 12, 2017
    Date of Patent: June 1, 2021
    Inventors: John McKew, Wei Zheng, Miao Xu, Manju Swaroop, Juan J. Marugan
  • CYCLODEXTRIN FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES
    Publication number: 20180110798
    Abstract: The invention provides for methods of treating lysosomal storage disorders and/or reduction of non-cholesterol lipids, using cyclodextrin compounds, including in combination with other therapeutics, including vitamin E.
    Type: Application
    Filed: June 12, 2017
    Publication date: April 26, 2018
    Inventors: John McKew, Wei Zheng, Miao Xu, Manju Swaroop, Juan J. Marugan
  • CYCLODEXTRIN FOR THE TREATMENT OF LYSOSOMAL STORAGE DISEASES
    Publication number: 20150216895
    Abstract: The invention provides for methods of treating lysosomal storage disorders and/or reduction of non-cholesterol lipids, using cyclodextrin compounds, including in combination with other therapeutics, including vitamin E.
    Type: Application
    Filed: August 3, 2013
    Publication date: August 6, 2015
    Inventors: John McKew, Wei Zheng, Miao Xu, Manju Swaroop, Juan J. Marugan